Dr. Nik Matthews, Genomics Manager in the Tumour Profiling Unit at The Institute of Cancer Research, London, with the new NovaSeq 6000 sequencer. Disclaimer: AAAS and EurekAlert! are not responsible ...
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing technology, today introduced the NovaSeq TM Series, a new and scalable sequencing ...
NovaSeq 6000 Sequencing System is designed to adapt to your needs so groundbreaking discoveries are always within reach. It's flexible, scalable science on your terms. NovaSeq 6000 offers deeper and ...
After a long wait, Illumina has revealed a new series of sequencing instruments—the NovaSeq X series, designed to cement its position as the leader in next-gen sequencing in the face of intense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback